Insider Trading activities of Co insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Co since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Co since year 2005. Table 2 shows the detailed insider transactions of Co since 2005. The reporting company's ticker symbol is LLY. The reporting company's CIK number is 59478.
The total value of stock buying since 2005 is $2,605,998.
The total value of stock sales since 2005 is $2,373,697,787.
The total value of stock option exercises since 2005 is $40,933,407.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Co (LLY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 205,000 $17,795,025 0 $0
2017-09 0 $0 385,000 $32,382,895 0 $0
2017-08 0 $0 180,000 $14,590,080 0 $0
2017-07 0 $0 220,000 $18,343,820 0 $0
2017-06 0 $0 449,733 $37,565,477 0 $0
2017-05 0 $0 25,000 $2,069,000 0 $0
2017-03 0 $0 210,000 $17,781,540 0 $0
2017-02 0 $0 478,162 $37,735,174 166,976 $0
2016-12 1,875 $135,805 223,335 $16,253,321 0 $0
2016-10 0 $0 2,248 $182,926 30,134 $0
2016-08 2,560 $205,875 0 $0 14,056 $0
2016-07 0 $0 881,213 $71,587,103 0 $0
2016-06 0 $0 435,992 $34,058,099 0 $0
2016-05 0 $0 390,000 $29,505,190 0 $0
2016-04 0 $0 380,000 $28,496,760 0 $0
2016-02 3,170 $249,225 34,583 $2,706,270 157,222 $0
2016-01 0 $0 5,000 $393,750 0 $0
2015-12 0 $0 655,000 $56,027,595 0 $0
2015-11 0 $0 205,000 $17,403,475 103,946 $5,839,684
2015-10 0 $0 675,000 $57,662,000 0 $0
2015-09 0 $0 250,000 $22,322,500 0 $0
2015-07 0 $0 25,000 $2,124,000 0 $0
2015-06 0 $0 630,000 $50,484,259 0 $0
2015-05 0 $0 805,200 $59,002,379 63,132 $3,442,818
2015-04 0 $0 0 $0 76,024 $4,271,028
2015-03 0 $0 374,000 $28,247,470 0 $0
2015-02 0 $0 156,470 $11,074,996 190,556 $507,642
2014-12 0 $0 370,000 $26,314,300 7,101 $395,170
2014-11 0 $0 400,750 $26,992,517 39,878 $2,224,133
2014-10 0 $0 590,126 $39,131,785 173,247 $8,614,860
2014-09 0 $0 615,000 $39,731,699 27,527 $1,532,656
2014-08 0 $0 0 $0 19,623 $1,094,239
2014-07 0 $0 527,065 $33,159,864 2,240 $0
2014-06 0 $0 865,000 $52,639,650 0 $0
2014-05 17,157 $1,015,093 630,000 $37,242,900 0 $0
2014-04 0 $0 350,000 $20,682,000 0 $0
2014-02 0 $0 19,648 $0 166,539 $0
2014-01 12,431 $0 0 $0 0 $0
2013-11 0 $0 0 $0 4,056 $0
2013-08 0 $0 5,000 $268,950 0 $0
2013-07 0 $0 12,500 $660,200 0 $0
2013-06 0 $0 5,000 $262,250 0 $0
2013-05 0 $0 15,000 $825,650 20,000 $0
2013-04 0 $0 8,500 $482,655 0 $0
2013-03 0 $0 24,000 $1,332,220 0 $0
2013-02 0 $0 37,646 $2,040,239 366,898 $0
2013-01 0 $0 15,000 $812,100 0 $0
2012-12 0 $0 0 $0 8,167 $0
2012-10 0 $0 10,000 $504,500 12,500 $0
2012-08 0 $0 5,000 $220,799 0 $0
2012-07 0 $0 5,000 $215,000 0 $0
2012-06 0 $0 7,125 $291,400 0 $0
2012-05 0 $0 8,295 $341,114 0 $0
2012-04 0 $0 2,000 $80,000 0 $0
2012-03 0 $0 2,000 $79,200 0 $0
2012-02 0 $0 29,284 $1,158,155 541,451 $0
2011-12 0 $0 5,787 $226,271 0 $0
2011-11 0 $0 10,700 $398,434 0 $0
2011-10 0 $0 5,700 $217,170 14,380 $0
2011-09 0 $0 5,700 $204,686 0 $0
2011-08 0 $0 5,700 $193,458 3,278 $0
2011-07 0 $0 10,700 $399,123 0 $0
2011-06 0 $0 15,700 $582,900 0 $0
2011-05 0 $0 9,078 $349,944 0 $0
2011-04 0 $0 17,700 $635,591 0 $0
2011-03 0 $0 16,000 $555,960 0 $0
2011-02 0 $0 74,170 $2,618,487 497,115 $0
2011-01 0 $0 3,100 $108,096 0 $0
2010-12 0 $0 3,100 $108,810 0 $0
2010-11 0 $0 3,100 $106,733 0 $0
2010-10 0 $0 3,100 $116,715 0 $0
2010-09 0 $0 3,100 $110,204 0 $0
2010-08 0 $0 3,100 $109,523 0 $0
2010-03 0 $0 8,811 $308,609 0 $0
2010-02 0 $0 10,200 $357,840 302,628 $0
2009-11 0 $0 2,673 $97,965 0 $0
2008-09 0 $0 512,000 $24,026,690 0 $0
2008-08 0 $0 2,228,908 $106,973,252 0 $0
2008-07 0 $0 513,900 $24,678,965 0 $0
2008-02 19,558 $1,000,000 29,822 $1,537,458 0 $0
2007-09 0 $0 720,033 $41,648,425 0 $0
2007-07 0 $0 249,400 $13,550,726 0 $0
2007-06 0 $0 129,533 $7,650,598 0 $0
2007-05 0 $0 2,602,859 $154,367,041 100,000 $5,479,999
2007-04 0 $0 1,187,954 $70,785,380 0 $0
2007-03 0 $0 7,289 $381,870 0 $0
2007-02 0 $0 17,382 $944,677 0 $0
2006-12 0 $0 153,700 $8,380,811 0 $0
2006-11 0 $0 1,433,200 $79,313,754 0 $0
2006-10 0 $0 576,750 $33,032,043 8,000 $276,760
2006-09 0 $0 539,950 $29,834,437 52,250 $1,807,587
2006-08 0 $0 2,466,500 $137,462,274 82,710 $2,861,352
2006-07 0 $0 572,000 $31,917,463 0 $0
2006-06 0 $0 815,000 $42,068,177 35,000 $1,210,825
2006-05 0 $0 3,425,800 $176,806,260 0 $0
2006-04 0 $0 321,800 $16,954,930 0 $0
2006-03 0 $0 1,617,800 $92,425,527 0 $0
2006-02 0 $0 27,370 $1,543,281 43,530 $1,374,654
2005-12 0 $0 5,000 $280,700 0 $0
2005-08 0 $0 3,710,300 $200,374,143 0 $0
2005-07 0 $0 521,500 $28,722,387 0 $0
2005-05 0 $0 861,800 $51,119,739 0 $0
2005-04 0 $0 642,200 $37,846,009 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Co insiders (LLY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-04 Lilly Endowment Inc (10% Owner) Sale 205,000 86.81 17,795,025
2017-09-29 Lilly Endowment Inc (10% Owner) Sale 195,000 85.28 16,630,185
2017-09-15 Lilly Endowment Inc (10% Owner) Sale 190,000 82.91 15,752,710
2017-08-31 Lilly Endowment Inc (10% Owner) Sale 180,000 81.06 14,590,080
2017-07-31 Lilly Endowment Inc (10% Owner) Sale 220,000 83.38 18,343,820
2017-06-22 Lilly Endowment Inc (10% Owner) Sale 210,000 84.43 17,730,720
2017-06-20 Lilly Endowment Inc (10% Owner) Sale 215,000 83.05 17,855,320
2017-06-12 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 1,900 80.78 153,482
2017-06-09 Harrington Michael J (Senior VP and General Counsel) Sale 22,833 79.97 1,825,955
2017-05-04 Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA) Sale 25,000 82.76 2,069,000
2017-03-30 Lilly Endowment Inc (10% Owner) Sale 210,000 84.67 17,781,540
2017-02-17 Lilly Endowment Inc (10% Owner) Sale 230,000 80.27 18,462,790
2017-02-06 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Sale 15,000 77.66 1,164,900
2017-02-03 Rice Derica W (EVP-Global Services and CFO) Sale 3,892 77.47 301,513
2017-02-02 Zakrowski Donald A (Chief Accounting Officer) Sale 2,000 77.52 155,040
2017-02-02 Rice Derica W (EVP-Global Services and CFO) Sale 7,270 76.97 559,571
2017-02-01 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Option Ex 6,659 .00 0
2017-02-01 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 3,073 .00 0
2017-02-01 Harrington Michael J (Senior VP and General Counsel) Option Ex 9,732 .00 0
2017-02-01 Ricks David A (President & CEO) Option Ex 10,244 .00 0
2017-02-01 Crowe Maria A (President, Mfg. Operations) Option Ex 8,195 .00 0
2017-02-01 Walsh Fionnuala M (SVP, Global Quality) Option Ex 4,610 .00 0
2017-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 7,683 .00 0
2017-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 15,366 .00 0
2017-02-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 10,244 .00 0
2017-02-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 10,244 .00 0
2017-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 5,634 .00 0
2017-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 9,732 .00 0
2017-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 19,463 .00 0
2017-02-01 Lechleiter John C Option Ex 46,097 .00 0
2017-02-01 Lilly Endowment Inc (10% Owner) Sale 220,000 77.69 17,091,360
2016-12-16 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 2,093 82.23 172,107
2016-12-16 Zakrowski Donald A (Chief Accounting Officer) Sale 1,000 72.13 72,130
2016-12-16 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 20,242 72.67 1,470,884
2016-12-16 Hoover R David Buy 500 71.85 35,925
2016-12-16 Tai Jackson P Buy 1,375 72.64 99,880
2016-12-16 Lilly Endowment Inc (10% Owner) Sale 200,000 72.69 14,538,200
2016-10-05 Crowe Maria A (President, Mfg. Operations) Sale 1,835 81.43 149,424
2016-10-04 Crowe Maria A (President, Mfg. Operations) Sale 413 81.12 33,502
2016-10-03 Crowe Maria A (President, Mfg. Operations) Option Ex 18,350 .00 0
2016-10-02 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 3,894 .00 0
2016-10-02 Crowe Maria A (President, Mfg. Operations) Option Ex 4,130 .00 0
2016-10-02 Walsh Fionnuala M (SVP, Global Quality) Option Ex 3,760 .00 0
2016-08-31 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 6,556 .00 0
2016-08-12 Tai Jackson P Buy 2,560 80.42 205,875
2016-08-03 Walsh Fionnuala M (SVP, Global Quality) Option Ex 7,500 .00 0
2016-07-29 Lilly Endowment Inc (10% Owner) Sale 205,000 82.94 17,001,880
2016-07-28 Zakrowski Donald A (Chief Accounting Officer) Sale 1,213 83.16 100,873
2016-07-28 Lilly Endowment Inc (10% Owner) Sale 240,000 82.97 19,913,280
2016-07-12 Lilly Endowment Inc (10% Owner) Sale 210,000 79.54 16,703,820
2016-07-07 Lilly Endowment Inc (10% Owner) Sale 225,000 79.41 17,867,250
2016-06-30 Lilly Endowment Inc (10% Owner) Sale 215,000 78.37 16,849,120
2016-06-29 Lilly Endowment Inc (10% Owner) Sale 220,000 77.89 17,135,800
2016-06-10 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Sale 992 73.77 73,179
2016-05-31 Lilly Endowment Inc (10% Owner) Sale 200,000 75.12 15,023,200
2016-05-12 Lilly Endowment Inc (10% Owner) Sale 190,000 76.22 14,481,990
2016-04-29 Lilly Endowment Inc (10% Owner) Sale 180,000 75.77 13,638,960
2016-04-08 Lilly Endowment Inc (10% Owner) Sale 200,000 74.29 14,857,800
2016-02-05 Fry Stephen F (SVP, HR & Diversity) Sale 15,230 78.87 1,201,190
2016-02-03 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 2,460 76.73 188,755
2016-02-03 Fry Stephen F (SVP, HR & Diversity) Sale 725 76.46 55,433
2016-02-03 Rice Derica W (EVP-Global Services and CFO) Sale 3,937 76.81 302,400
2016-02-01 Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) Option Ex 2,072 .00 0
2016-02-01 Harrington Michael J (Senior VP and General Counsel) Option Ex 9,066 .00 0
2016-02-01 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 3,273 78.36 256,472
2016-02-01 Ricks David A (SVP and Pres, Lilly Bio-Meds) Option Ex 9,843 .00 0
2016-02-01 Crowe Maria A (President, Mfg. Operations) Option Ex 7,252 .00 0
2016-02-01 Walsh Fionnuala M (SVP, Global Quality) Option Ex 4,144 .00 0
2016-02-01 Fry Stephen F (SVP, HR & Diversity) Sale 2,412 78.39 189,076
2016-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 7,252 .00 0
2016-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 15,541 .00 0
2016-02-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 9,843 .00 0
2016-02-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 10,360 .00 0
2016-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 5,698 .00 0
2016-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 9,843 .00 0
2016-02-01 Rice Derica W (EVP-Global Services and CFO) Sale 6,546 78.36 512,944
2016-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 19,685 .00 0
2016-02-01 Lechleiter John C (Chairman, President and CEO) Option Ex 46,623 .00 0
2016-02-01 Tai Jackson P Buy 3,170 78.62 249,225
2016-01-29 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Sale 5,000 78.75 393,750
2015-12-21 Lilly Endowment Inc (10% Owner) Sale 205,000 86.00 17,630,000
2015-12-15 Lilly Endowment Inc (10% Owner) Sale 215,000 85.59 18,402,925
2015-12-09 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 25,000 83.88 2,097,000
2015-12-02 Lilly Endowment Inc (10% Owner) Sale 210,000 85.23 17,897,670
2015-11-23 Walsh Fionnuala M (SVP, Global Quality) Option Ex 9,036 56.18 507,642
2015-11-20 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Option Ex 12,048 56.18 676,856
2015-11-20 Lilly Endowment Inc (10% Owner) Sale 205,000 84.89 17,403,475
2015-11-12 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 6,928 56.18 389,215
2015-11-05 Ricks David A (SVP and Pres, Lilly Bio-Meds) Option Ex 4,970 56.18 279,214
2015-11-03 Lechleiter John C (Chairman, President and CEO) Option Ex 70,964 56.18 3,986,757
2015-10-29 Lilly Endowment Inc (10% Owner) Sale 200,000 82.63 16,525,800
2015-10-09 Lilly Endowment Inc (10% Owner) Sale 215,000 86.14 18,520,100
2015-10-05 Lilly Endowment Inc (10% Owner) Sale 260,000 86.98 22,616,100
2015-09-18 Lilly Endowment Inc (10% Owner) Sale 250,000 89.29 22,322,500
2015-07-28 Mahony Susan (SVP & Pres., Lilly Oncology) Sale 25,000 84.96 2,124,000
2015-06-10 Lilly Endowment Inc (10% Owner) Sale 210,000 82.78 17,383,380
2015-06-04 Lilly Endowment Inc (10% Owner) Sale 200,000 78.20 15,640,799
2015-06-01 Lilly Endowment Inc (10% Owner) Sale 220,000 79.36 17,460,080
2015-05-29 Zakrowski Donald A (Chief Accounting Officer) Sale 200 78.33 15,666
2015-05-29 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Sale 20,000 78.08 1,561,600
2015-05-20 Lilly Endowment Inc (10% Owner) Sale 190,000 73.43 13,951,320
2015-05-15 Lilly Endowment Inc (10% Owner) Sale 200,000 72.83 14,566,399
2015-05-08 Lilly Endowment Inc (10% Owner) Sale 195,000 73.28 14,289,795
2015-05-05 Crowe Maria A (President, Mfg. Operations) Option Ex 6,024 56.18 338,428
2015-05-05 Rice Derica W (EVP-Global Services and CFO) Option Ex 57,108 54.36 3,104,390
2015-05-01 Lilly Endowment Inc (10% Owner) Sale 200,000 73.09 14,617,599
2015-04-28 Harrington Michael J (Senior VP and General Counsel) Option Ex 6,024 56.18 338,428
2015-04-28 Lechleiter John C (Chairman, President and CEO) Option Ex 70,000 56.18 3,932,600
2015-03-30 Lilly Endowment Inc (10% Owner) Sale 180,000 73.94 13,308,660
2015-03-23 Lilly Endowment Inc (10% Owner) Sale 190,000 77.17 14,661,730
2015-03-09 Fry Stephen F (SVP, HR & Diversity) Sale 4,000 69.27 277,080
2015-02-11 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 9,036 56.18 507,642
2015-02-05 Zakrowski Donald A (Chief Accounting Officer) Sale 374 71.03 26,565
2015-02-04 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 3,147 69.99 220,258
2015-02-04 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Sale 11,085 70.08 776,836
2015-02-04 Rice Derica W (EVP-Global Services and CFO) Sale 5,316 70.00 372,120
2015-02-03 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Sale 71,711 70.72 5,071,401
2015-02-02 Ricks David A (SVP and Pres, Lilly Bio-Meds) Sale 4,769 71.51 341,031
2015-02-02 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Sale 50,000 70.87 3,543,500
2015-02-02 Rice Derica W (EVP-Global Services and CFO) Sale 10,068 71.84 723,285
2015-02-01 Ricks David A (SVP and Pres, Lilly Bio-Meds) Option Ex 12,591 .00 0
2015-02-01 Crowe Maria A (President, Mfg. Operations) Option Ex 9,094 .00 0
2015-02-01 Walsh Fionnuala M (SVP, Global Quality) Option Ex 5,246 .00 0
2015-02-01 Fry Stephen F (SVP, HR & Diversity) Option Ex 8,394 .00 0
2015-02-01 Lundberg Jan M (EVP,Science&Tech and Pres. LRL) Option Ex 20,985 .00 0
2015-02-01 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 12,591 .00 0
2015-02-01 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 13,990 .00 0
2015-02-01 Peterson Barton R (Sr. VP, Corp. Affairs & Comm.) Option Ex 6,995 .00 0
2015-02-01 Mahony Susan (SVP & Pres., Lilly Oncology) Option Ex 12,591 .00 0
2015-02-01 Rice Derica W (EVP-Global Services and CFO) Option Ex 26,581 .00 0
2015-02-01 Lechleiter John C (Chairman, President and CEO) Option Ex 52,462 .00 0
2014-12-10 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Option Ex 7,101 55.65 395,170
2014-12-04 Lilly Endowment Inc (10% Owner) Sale 190,000 71.92 13,664,800
2014-12-02 Lilly Endowment Inc (10% Owner) Sale 180,000 70.28 12,649,500
2014-11-19 Simmons Jeffrey N (SVP&Pres. Elanco Animal Health) Option Ex 18,576 55.91 1,038,677
2014-11-13 Lilly Endowment Inc (10% Owner) Sale 200,000 67.73 13,546,000
2014-11-11 Zakrowski Donald A (Chief Accounting Officer) Sale 750 68.49 51,367
2014-11-07 Zulueta Alfonso G (SVP& Pres., Emerging Markets) Option Ex 21,302 55.65 1,185,456
2014-11-05 Lilly Endowment Inc (10% Owner) Sale 180,000 67.00 12,060,000
2014-11-04 Walsh Fionnuala M (SVP, Global Quality) Sale 15,000 67.00 1,005,000
2014-11-03 Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes) Sale 5,000 66.03 330,150
2014-10-31 Walsh Fionnuala M (SVP, Global Quality) Sale 7,376 66.58 491,094
2014-10-31 Walsh Fionnuala M (SVP, Global Quality) Option Ex 20,537 55.83 1,146,519
2014-10-31 Lilly Endowment Inc (10% Owner) Sale 190,000 66.69 12,671,100
2014-10-30 Lilly Endowment Inc (10% Owner) Sale 175,000 66.75 11,682,125
2014-10-29 Lechleiter John C (Chairman, President and CEO) Option Ex 127,811 55.65 7,112,682
2014-10-27 Crowe Maria A (President, Mfg. Operations) Option Ex 6,391 55.65 355,659
2014-10-24 Crowe Maria A (President, Mfg. Operations) Sale 2,750 65.77 180,867
2014-10-06 Lilly Endowment Inc (10% Owner) Sale 210,000 65.63 13,782,299
2014-10-03 Crowe Maria A (President, Mfg. Operations) Option Ex 9,175 .00 0
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.